WELLINGTON MANAGEMENT GROUP LLP - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q1 2021$340,000
-33.7%
4,597
-34.1%
0.00%
Q4 2020$513,000
-34.9%
6,980
-51.4%
0.00%
Q3 2020$788,000
-48.4%
14,370
-37.4%
0.00%
Q2 2020$1,528,000
-22.3%
22,972
-28.5%
0.00%
-100.0%
Q1 2020$1,967,000
-39.8%
32,138
-13.5%
0.00%0.0%
Q4 2019$3,268,000
+18.7%
37,161
+1.8%
0.00%0.0%
Q3 2019$2,754,000
-11.6%
36,4950.0%0.00%0.0%
Q2 2019$3,117,000
-26.3%
36,495
-6.7%
0.00%0.0%
Q1 2019$4,228,000
+23.7%
39,114
-3.1%
0.00%0.0%
Q4 2018$3,418,000
-13.9%
40,3820.0%0.00%0.0%
Q3 2018$3,969,000
-34.3%
40,382
-22.6%
0.00%0.0%
Q2 2018$6,039,000
+9.5%
52,196
-6.6%
0.00%0.0%
Q1 2018$5,517,000
-5.7%
55,8660.0%0.00%0.0%
Q4 2017$5,849,000
-11.4%
55,866
-4.6%
0.00%
-50.0%
Q3 2017$6,601,000
-32.6%
58,573
-32.9%
0.00%0.0%
Q2 2017$9,788,000
-37.6%
87,341
-35.1%
0.00%
-50.0%
Q1 2017$15,685,000
-21.6%
134,500
-29.2%
0.00%
-20.0%
Q4 2016$19,997,000
+1.0%
189,953
+6.0%
0.01%0.0%
Q3 2016$19,805,000
+61.3%
179,216
+112.5%
0.01%
+66.7%
Q2 2016$12,282,000
+15.5%
84,351
+13.6%
0.00%0.0%
Q1 2016$10,634,000
+1304.8%
74,233
+1415.0%
0.00%
Q4 2015$757,000
+8.1%
4,9000.0%0.00%
Q3 2015$700,0004,9000.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders